FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Ascend Laboratories Aripiprazole Tablets Recall

Aripiprazole Tablets, USP, 20 mg, Rx Only, Packaged in 500-count bottle Manufactured by…

Ascend Laboratories, LLC · Parsippany, NJ

Risk level
Class II
Reported by FDA
Apr 26, 2023
Recall ID
D-0539-2023
Check your lot numberHow we source this data

Summary

Ascend Laboratories recalled Aripiprazole Tablets starting Mar 17, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0539-2023 on Apr 26, 2023. Reason: Out of specification (OOS) for Spectroscopic Identification test by IR. Status: Ongoing.

Why it was recalled

Out of specification (OOS) for Spectroscopic Identification test by IR.

Product description

Aripiprazole Tablets, USP, 20 mg, Rx Only, Packaged in 500-count bottle Manufactured by: Alkem Laboratories Ltd., INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC#: 67877-434-05

Lot numbers, UPCs & expiration codes

Lot #22143120, Exp. Date: June 2024

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0539-2023
Classification
Class II
Status
Ongoing
Recall initiated
Mar 17, 2023
FDA report date
Apr 26, 2023
Quantity
135 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Ascend Laboratories, LLC

Original FDA data

Every field from FDA enforcement report D-0539-2023, exactly as published.

Show all FDA fields
City
Parsippany
State
NJ
Status
Ongoing
Country
United States
Event ID
91918
Address
339 Jefferson Rd Ste 101
Code information
Lot #22143120, Exp. Date: June 2024
Postal code
07054-3707
Report date
Apr 26, 2023
Product type
Drugs
Recall number
D-0539-2023
Classification
Class II
Recalling firm
Ascend Laboratories, LLC
Product quantity
135 bottles
Reason for recall
Out of specification (OOS) for Spectroscopic Identification test by IR.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Aripiprazole Tablets, USP, 20 mg, Rx Only, Packaged in 500-count bottle Manufactured by: Alkem Laboratories Ltd., INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC#: 67877-434-05
Distribution pattern
Nationwide in the USA
Recall initiation date
Mar 17, 2023
Initial firm notification
Letter
Center classification date
Apr 19, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0539-2023, published Apr 26, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls